12.5 units of semaglutide FDA alerts health care providers, compounders and patients dosing errors associated with compounded injectable products Semaglutide/Glycine/B12 | Strive Pharmacy

Terushkin is exceptionally qualified to guide patients through their weight loss journey

GLP-1 as a trend has grown by 1054% in social discussion over the past year, according to Tastewise, a GenAI-powered consumer data platform (see graph below)

Prior to that date, only injectable GLP-1 treatments (such as Ozempic) had been approved

While many employer groups still don't cover drugs for obesity or weight loss at all, those who do are increasingly recognizing that medication alone isn't enough

Why choose Continental Hospitals

A dose-escalation schedule (1.5 mg 4 mg 9 mg 25 mg, a month at each step) is followed to reduce gastrointestinal side effects